Abiopharma

KINGSWAY FINANCIAL SERVICES INC (KFS) Reports the reporting period Financial Results KINGSWAY FINANCIAL SERVICES INC (KFS) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: $39
• Net Income: (9,059
• EPS: Not disclosed
• Cash and equivalents: $2
  • 0 million as of March 31, 2026; see “Non
  • U.S. GAAP Financial Measures” below for further explanation of this metric. ● On March 16, 2026, the Company announced that its Board of Directors (the “Board”) had elected Adam J. Patinkin as Chairman of the Board and Terence M. Kavanagh as Vice
  • Chairman of the Board. ● On March 31, 2026, the Company announced the Board had approved a proposed corporate name change to Kingsway Corporation and a proposed stock ticker change to KWY, which are intended to better reflect the Company’s business evolution and long
    • anticipated in the forward-looking statements, please refer to the section entitled "Risk Factors" in the Company's 2025